This HTML5 document contains 41 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n9http://linked.opendata.cz/resource/drugbank/drug/DB02640/identifier/chebi/
n10http://linked.opendata.cz/resource/drugbank/drug/DB02640/identifier/wikipedia/
n5http://bio2rdf.org/drugbank:
n16http://linked.opendata.cz/resource/drugbank/drug/DB02640/identifier/pdb/
n14http://linked.opendata.cz/resource/drugbank/drug/DB02640/identifier/kegg-compound/
admshttp://www.w3.org/ns/adms#
n12http://linked.opendata.cz/resource/drugbank/drug/DB02640/identifier/pubchem-compound/
n13http://linked.opendata.cz/resource/drugbank/drug/DB02640/identifier/pubchem-substance/
n7http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n11http://linked.opendata.cz/resource/drugbank/drug/DB02640/identifier/drugbank/
n3http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB02640
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n5:DB02640 n7:DB02640
dcterms:title
Fumagillin
adms:identifier
n9:48635 n10:Fumagillin n11:DB02640 n12:46936444 n13:46505331 n14:C09668 n16:FUG
n3:synthesisReference
Peterson, M.H., Goldstein, A.W. and Denison, F.W. Jr.; U.S. Patent 2,803,586; August 20, 1957; assigned to Abbott Laboratories.
n3:IUPAC-Name
n6:271B4A4F-363D-11E5-9242-09173F13E4C5
n3:InChI
n6:271B4A55-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n6:271B4A54-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n6:271B4A51-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n6:271B4A52-363D-11E5-9242-09173F13E4C5
n3:SMILES
n6:271B4A53-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n6:271B4A4D-363D-11E5-9242-09173F13E4C5
n3:logP
n6:271B4A4B-363D-11E5-9242-09173F13E4C5 n6:271B4A4E-363D-11E5-9242-09173F13E4C5
n3:logS
n6:271B4A4C-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n6:271B4A5B-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n6:271B4A5C-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n6:271B4A56-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n6:271B4A57-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n6:271B4A59-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n6:271B4A58-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n6:271B4A5A-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
23110-15-8
n3:Bioavailability
n6:271B4A61-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n6:271B4A63-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n6:271B4A64-363D-11E5-9242-09173F13E4C5
n3:Melting-Point
n6:271B4A65-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n6:271B4A60-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n6:271B4A5F-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n6:271B4A62-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n6:271B4A50-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n6:271B4A5D-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n6:271B4A5E-363D-11E5-9242-09173F13E4C5